Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-13

Clinical Trial Update: Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure

View source ↗

Summary

A completed clinical trial assessing safety and intraocular pressure-lowering effects of Travoprost Evolute® delivered to subjects with elevated intraocular pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost Evolute® (travoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Elevated Intraocular Pressure (IOP) | Status: COMPLETED | Results posted: 2023-09-13